Status:
COMPLETED
A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors
Lead Sponsor:
Pasche, Boris, M.D.
Collaborating Sponsors:
Barbault, Alexandre, M.S.
Conditions:
Cancer
Brain Tumor
Eligibility:
All Genders
18-95 years
Phase:
EARLY_PHASE1
Brief Summary
In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We have develo...
Detailed Description
Background: In vitro studies suggest that low levels of amplitude-modulated electromagnetic fields may modify cell growth. We have identified specific frequencies that may block cancer cell growth. We...
Eligibility Criteria
Inclusion
- Advanced tumor that is either metastatic or inoperable
Exclusion
- Pregnancy,
- Other simultaneous anticancer therapies,
- ECOG performance status less than 3
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2007
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00440570
Start Date
October 1 2004
End Date
December 1 2007
Last Update
June 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet Médical Avenue de la gare 6
Lausanne, Canton of Vaud, Switzerland, 1012